Edwards Lifesciences (EW) Current Deferred Tax Assets (2009 - 2015)

Edwards Lifesciences has reported Current Deferred Tax Assets for 7 years, with the latest figure at $79.0 million in Q3 2015.

• On a quarterly basis, Current Deferred Tax Assets rose 167.8% year-over-year to $79.0 million in Q3 2015; TTM through Sep 2015 was $79.0 million, a 167.8% increase from a year earlier, with the FY2014 full-year figure at $63.5 million, up 90.12% from the prior year.
• Current Deferred Tax Assets was $79.0 million for Q3 2015 at Edwards Lifesciences, up from $65.2 million in the prior quarter.
• The five-year high for Current Deferred Tax Assets was $79.0 million in Q3 2015, with the low at $25.3 million in Q3 2011.
• Average Current Deferred Tax Assets over 5 years is $44.9 million, with a median of $42.4 million recorded in 2012.
• The sharpest annual moves came in 2012 and 2015: Current Deferred Tax Assets plunged 43.57% in 2012, then soared 167.8% in 2015.
• Over 5 years, Current Deferred Tax Assets stood at $43.9 million in 2011, then decreased by 1.14% to $43.4 million in 2012, then dropped by 23.04% to $33.4 million in 2013, then soared by 90.12% to $63.5 million in 2014, then climbed by 24.41% to $79.0 million in 2015.
• The last three Current Deferred Tax Assets figures came in at $79.0 million (Q3 2015), $65.2 million (Q2 2015), and $57.0 million (Q1 2015), per Business Quant data.